Investment Rating - The report maintains a "Recommended" rating for the company, indicating an expected stock price increase of over 15% relative to the benchmark index [4][5]. Core Insights - The company is projected to achieve a net profit attributable to shareholders of between 176 million to 200 million yuan in 2025, representing a year-on-year growth of 67% to 89%. The non-recurring net profit is expected to be between 170 million to 194 million yuan, with a growth of 60% to 83% [1]. - The growth in revenue is primarily driven by the strong performance of proprietary brands and brand management, alongside improved internal management efficiency [2]. - The company has established a long-term strategic partnership with Meisidike, which is expected to enhance its market presence in China [2]. Summary by Sections Revenue and Profit Forecast - The company anticipates revenues of 3.28 billion yuan in 2025, with a growth rate of 85.8%. By 2026 and 2027, revenues are expected to reach 5.54 billion yuan and 7.17 billion yuan, respectively, with growth rates of 68.8% and 29.6% [11]. - The net profit attributable to shareholders is forecasted to be 1.87 billion yuan in 2025, 4.00 billion yuan in 2026, and 5.42 billion yuan in 2027, with respective growth rates of 76.9%, 113.9%, and 35.7% [11]. Brand Performance - The proprietary brand "Zhanjia" continues to expand its product offerings, including a new strategic product, fragrance laundry detergent, which has seen rapid market acceptance [2][3]. - The brand "Feicui" targets the oral beauty market with a mid-to-high-end product positioning, achieving retail sales exceeding 500 million yuan within 12 months of launch [3]. - "Niu Yibei" focuses on the high cost-performance market, complementing "Feicui" and enhancing the company's overall product portfolio in the health sector [3]. Operational Efficiency - The company is implementing a refined operational strategy to reduce costs and improve resource utilization efficiency [2]. - The internal management improvements are expected to contribute significantly to the overall profitability and operational effectiveness of the company [2].

Investment Rating - The report maintains a "Recommended" rating for the company, indicating an expected stock price increase of over 15% relative to the benchmark index [4][5]. Core Insights - The company is experiencing significant growth in its proprietary brands, with a projected net profit for 2025 expected to be between 176 million to 200 million yuan, representing a year-on-year increase of 67% to 89% [1]. - The growth is attributed to the high revenue from proprietary brands and brand management, alongside improved internal management efficiency [2]. - The company is focusing on three proprietary brands: "Zhanjia," "Feicui," and "Niuyibei," which are expanding in the home cleaning and health product sectors [3]. Financial Projections - Revenue projections for 2025, 2026, and 2027 are 3.28 billion, 5.54 billion, and 7.17 billion yuan, respectively, with growth rates of 85.8%, 68.8%, and 29.6% [4]. - The expected net profit for the same years is 187 million, 400 million, and 542 million yuan, with year-on-year growth rates of 76.9%, 113.9%, and 35.7% [4]. - Earnings per share (EPS) are projected to be 0.60, 1.29, and 1.74 yuan for 2025, 2026, and 2027, respectively [4].